Announcements Trials

Browse Landscape

Phase

Status

Unknown 4 Completed 3 Recruiting 2 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Motor Activity 9 Neoplasms 4 Breast Neoplasms 3 Weight Loss 2 Ventricular Dysfunction, Left 1 Urinary Incontinence 1 Sexual Dysfunction, Physiological 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Melanoma 1 Lymphoma 1 Leukemia 1 Insulin Resistance 1 Hypoxia 1 Hematologic Neoplasms 1 Heart Failure 1 Head and Neck Neoplasms 1 Fecal Incontinence 1 Fatigue 1 Cardiotoxicity 1 Carcinoma, Renal Cell 1 Cachexia 1 Brenner Tumor 1 Breast Diseases 1 Brain Neoplasms 1 Bone Metastases 1 Body Weight 1

Interventions

Cyclophosphamide 14 fludarabine 10 fludarabine phosphate 8 Whole-Body Irradiation 7 thymoglobulin 5 Thiotepa 5 Tacrolimus 5 Stem Cell Transplantation 5 Nivolumab 5 Granulocyte Colony-Stimulating Factor 5 Busulfan 5 Azacitidine 5 venetoclax 4 Standard of Care 4 Radiotherapy 4 Practice Guidelines as Topic 4 Mycophenolic Acid 4 Methotrexate 4 Melphalan 4 Filgrastim 4 Cytarabine 4 Antilymphocyte Serum 4 Rituximab 3 Mesna 3 Leucovorin 3 Dexamethasone 3 Calcium Dobesilate 3 Alemtuzumab 3 ruxolitinib 2 ceritinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hematologic Neoplasms × Exercise × Clear all

NCT04081298 2023-07-03

MiVSEEV

Fred Hutchinson Cancer Center

Phase NA Terminated

20 enrolled 34 charts

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡